| Diagnosis of coronary artery disease with dobutamine-stress MRI. | |
| | |
MedLine Citation:
|
PMID: 15801057 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Dobutamine-stress cardiovascular magnetic resonance (CMR) is a new diagnostic tool for the non-invasive detection of coronary artery disease. Technological advances in CMR have evolved this technique to an adequate alternative to the standard cardiac stress tests. Its high reproducibility and excellent image quality of the anatomical features of the left ventricle and left ventricular function at rest and during stress make it an ideal technique for the comprehensive evaluation of patients with suspected coronary artery disease. Besides its ability to detect myocardial ischemia, CMR has proved to be diagnostic for myocardial viability as well. A recent technical refinement in CMR using myocardial tagging has improved the diagnostic accuracy for myocardial ischemia even further. Dobutamine-stress CMR is used to identify wall motion abnormalities of the left ventricle in patients with proven or suspected coronary artery disease [1-4]. Dobutamine-stress CMR has emerged as a highly accurate and safe diagnostic modality [1-4]. Recently, the use of high-dose dobutamine CMR in combination with the myocardial tagging technique has been reported, with excellent diagnostic results. The use of this new technique and the clinical applications are discussed. |
| | |
Authors:
|
Dirkjan Kuijpers |
Related Documents
:
|
12931107 - Relationship between dobutamine response of dyssynergic myocardium and angiographically... 9396877 - Comparison of dobutamine stress echocardiography and technetium-99m sestamibi single-ph... 2786807 - Support, stress, and recovery from coronary heart disease: a longitudinal causal model. 9264417 - Impact of acute propranolol administration on dobutamine-induced myocardial ischemia as... 14517987 - Myocardial volume and organization are changed by failure of addition of secondary hear... 17646607 - Association between increased mortality and mild thyroid dysfunction in cardiac patients. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: European radiology Volume: 15 Suppl 2 ISSN: 0938-7994 ISO Abbreviation: Eur Radiol Publication Date: 2005 Feb |
Date Detail:
|
Created Date: 2005-03-31 Completed Date: 2005-06-24 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9114774 Medline TA: Eur Radiol Country: Germany |
Other Details:
|
Languages: eng Pagination: B48-51 Citation Subset: IM |
Affiliation:
|
Department of Radiology, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands. kps@xs4all.nl |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adrenergic beta-Agonists
/
diagnostic use* Coronary Disease / diagnosis* Dobutamine / diagnostic use* Exercise Test / methods* Humans Image Enhancement Magnetic Resonance Imaging / methods* Magnetic Resonance Imaging, Cine / methods Myocardial Ischemia / diagnosis Myocardium / pathology Reproducibility of Results Tissue Survival Ventricular Dysfunction, Left / diagnosis Ventricular Function, Left / physiology |
| Chemical | |
Reg. No./Substance:
|
0/Adrenergic beta-Agonists; 34368-04-2/Dobutamine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Role of CMR in assessment of myocardial perfusion.
Next Document: Delayed contrast-enhanced MRI: use in myocardial viability assessment and other cardiac pathology.